TPST
$2.27
Market ClosedAs of Mar 17, 8:00 PM UTC
Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer.
Recent News
No recent news found.
$2.27
Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer.